Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
D-Luciferin sodium salt (AC149)
Cat.#: ASSD-149
Specifications
Description D-luciferin sodium salt, a water-soluble chemiluminescent luciferase substrate, is commonly used for in vivo and in vitro imaging of the expression of luciferase. The compound is nontoxic and stable in cells and live animals. Size 10 mg, 50 mg, 100 mg Chemical Name (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid sodium salt Molecule Weight 302.3 Molecular formula C11H7N2NaO3S2 CAS Number 103404-75-7 PubChem identifier 5702588 MDL Number MFCD00044938 Purity >98% Solubility Soluble in water (100 mM), and in DMSO (100 mM) Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-177 Fluorescein 5-Maleimide (AC177) 25 mg inquiry ASSD-219 Tetramethylrhodamine-6-maleimide (AC219) 5 mg inquiry ASSD-168 Indo-1 AM (AC168) 1 mg inquiry ASSD-147 Rhodamine phalloidin-TRITC (AC147) 300 tests, 100μg inquiry ASSD-213 Fluorescein 6-Maleimide (AC213) 25 mg, 250 mg inquiry ASSD-228 ImmunoHistoMount (AC228) 30 ml inquiry ASSD-116 Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) 1 kit, 100 tests inquiry ASSD-132 Congo Red (AC132) 100 mg, 1g inquiry ASSD-122 Fluorescent β2 antagonist [(±)-propranolol] (AC122) 500 μg inquiry ASSD-102 DAPI (AC102) 10 mg, 50 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket